Surgeon specialist in Greenlawn, New York

Eric Seitelman, MD is a board certified Surgeon specializing in Complex Surgical Oncology located at 5 Cuba Hill Road, Greenlawn, New York, United States. Dr. Seitelman is the Program Director of Icahn School of Medicine at South Nassau General Surgery Residency. With a focus on melanoma, sarcoma, breast cancer, and GI malignancies, he works closely with a multidisciplinary team to provide the best care for his patients. Dr. Seitelman has established a thriving surgical oncology practice and is actively involved in South Nassau's tumor board and surgical conferences. Patients should inquire about their physician's industry relationships and can find information on insurance and health plan networks on the Mount Sinai Health System website.

Mount Sinai Doctors Long Island, located at 5 Cuba Hill Road in Greenlawn, New York, is a premier healthcare institution offering a wide range of medical services. Whether you are in need of a family doctor or a specialist in areas such as cancer, cardiology, gastroenterology, rheumatology, or surgery, our team of experts is here to provide you with advanced treatments and personalized care. As part of the Mount Sinai Health System, we have the ability to coordinate referrals to other specialists as needed, ensuring that you receive comprehensive care. Our goal is to build lifelong relationships with our patients and keep you in the best possible health. Experience unparalleled medical services and compassionate care at Mount Sinai Doctors Long Island.

Welcome to Mount Sinai Doctors Long Island: Gorevic Peter MD, where exceptional healthcare meets personalized attention. Located at 5 Cuba Hill Road in Greenlawn, New York, our practice is dedicated to providing top-notch medical services to the community. Whether you're in search of a trusted family doctor or require specialized care, our team of experts is here to meet your health needs. At Mount Sinai Doctors-Long Island, we offer a comprehensive range of services, including expertise in cancer, cardiology, gastroenterology, rheumatology, surgery, and more. Our commitment to advanced treatments and compassionate care ensures that you receive the highest standard of medical attention. As part of the renowned Mount Sinai Health System, we have the capability to seamlessly arrange referrals to other specialists whenever necessary.

Welcome to the practice of Dr. Ashutosh (Ash) K. Tewari, MBBS, MCh, FRCS (Hon), located at 5 Cuba Hill Road, Greenlawn, New York. Dr. Tewari is a distinguished urologist and prostate cancer specialist, currently serving as the Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. With an impressive career, Dr. Tewari has performed over 5,000 robotic radical prostatectomy surgeries, making his case series one of the largest globally and establishing his outcomes as the gold standard in the field. Dr. Tewari is dedicated to advancing prostate cancer treatment through his leadership at the Tewari Lab, where groundbreaking research into the genomic causes of prostate cancer is underway. His work translates genomic insights into practical applications for physicians, leveraging advanced imaging techniques. Recognized for his contributions, Dr. Tewari received the prestigious American Urological Association’s Gold Cystoscope Award in 2012.

Welcome to the practice of Michael Gorin, MD, where exceptional urologic care meets cutting-edge research and innovation. Conveniently located at 5 Cuba Hill Road, Greenlawn, New York, Dr. Gorin is a highly esteemed Associate Professor in the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. He specializes in treating a wide range of urologic conditions, including enlarged prostate symptoms, kidney stones, kidney tumors, and prostate cancer. As a fellowship-trained endourologist, Dr. Gorin offers the most advanced minimally invasive treatment options to his patients. Dr. Gorin is not only a skilled surgeon but also a pioneering clinical researcher. He is renowned for his work in molecular imaging for diagnosing and managing urologic malignancies. Notably, he was part of the first clinical team to explore PSMA-targeted PET imaging with PYLARIFY, leading to its FDA approval. This breakthrough imaging technique has since benefited countless prostate cancer patients.